B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 47.48 CNY -0.79% Market Closed
Market Cap: 20B CNY

Intrinsic Value

The intrinsic value of one Betta Pharmaceuticals Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 47.48 CNY, Betta Pharmaceuticals Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Betta Pharmaceuticals Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Betta Pharmaceuticals Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Betta Pharmaceuticals Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Betta Pharmaceuticals Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Betta Pharmaceuticals Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Betta Pharmaceuticals Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Betta Pharmaceuticals Co Ltd.

Explain Valuation
Compare Betta Pharmaceuticals Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Betta Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Betta Pharmaceuticals Co Ltd

Current Assets 1.4B
Cash & Short-Term Investments 577.5m
Receivables 429.6m
Other Current Assets 351.6m
Non-Current Assets 7.8B
Long-Term Investments 1.3B
PP&E 3B
Intangibles 3.4B
Other Non-Current Assets 110.9m
Current Liabilities 1.8B
Accounts Payable 579.8m
Accrued Liabilities 259.5m
Short-Term Debt 152.5m
Other Current Liabilities 764.7m
Non-Current Liabilities 1.8B
Long-Term Debt 1.5B
Other Non-Current Liabilities 299.7m
Efficiency

Free Cash Flow Analysis
Betta Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Betta Pharmaceuticals Co Ltd

Revenue
3.3B CNY
Cost of Revenue
-731m CNY
Gross Profit
2.5B CNY
Operating Expenses
-2B CNY
Operating Income
559m CNY
Other Expenses
-255.7m CNY
Net Income
303.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Betta Pharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Healthy Operating Margin
hidden
Profitability
Score

Betta Pharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Betta Pharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Betta Pharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Betta Pharmaceuticals Co Ltd

Wall Street analysts forecast Betta Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 65.07 CNY with a low forecast of 45.03 CNY and a high forecast of 87.15 CNY.

Lowest
Price Target
45.03 CNY
5% Downside
Average
Price Target
65.07 CNY
37% Upside
Highest
Price Target
87.15 CNY
84% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Betta Pharmaceuticals Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Betta Pharmaceuticals Co Ltd stock?

The intrinsic value of one Betta Pharmaceuticals Co Ltd stock under the Base Case scenario is hidden CNY.

Is Betta Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 47.48 CNY, Betta Pharmaceuticals Co Ltd is hidden .

Back to Top